Respiratory Disease Genetic Testing Market
完整報告名稱與涵蓋範圍
Respiratory Disease Genetic Testing Market Size, Share & Trends Analysis Report By Offerings (Products (Kits and Consumables), Services, Others), By Disease Type, By Offerings (PCR, NGS (Whole Genome Sequencing, Whole Exome Sequencing), Others, By Trait Type (Inherited Trait, Acquired Trait), By Age Group, By End-User, By Region, And By Segment Forecasts, 2023-2031
報告摘要
The Respiratory Disease Genetic Testing Market is positioned for steady expansion, with a projected CAGR of 5.34% from 2023 to 2031.
At its core, Respiratory Disease Genetic Testing pertains to a pathological condition that affects the respiratory system, primarily the lungs. Stakeholders across the healthcare landscape are surgingly turning to these solutions to meet contemporary demands.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold notable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and surging investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Respiratory Disease Genetic Testing Market Snapshot
Chapter 4. Global Respiratory Disease Genetic Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Trait Type Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Offering Estimates & Trend Analysis
5.1. By Offering, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Offering:
5.2.1. Products
5.2.1.1. Kits and Consumables
5.2.2. Services
5.2.3. Others
Chapter 6. Market Segmentation 2: By Specialty Type Estimates & Trend Analysis
6.1. By Specialty Type & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Specialty Type:
6.2.1. COPD (Alpha-1-antitrypsin (AAT)
6.2.2. Cystic Fibrosis (CF)
6.2.3. Diffuse Lung Disease/Surfactant Dysfunction
6.2.3.1. RHD (Respiratory Distress Syndrome)
6.2.3.2. PPHN (Persistent Pulmonary Hypertension of the Newborn)
6.2.4. Interstitial lung disease
6.2.5. Pulmonary Arterial Hypertension
6.2.6. Pulmonary Hypoplasia
6.2.7. Primary Ciliary Dyskinesia
6.2.8. Other Diseases (BPD)
Chapter 7. Market Segmentation 3: By Trait Type Estimates & Trend Analysis
7.1. By Trait Type & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Trait Type:
7.2.1. Inherited Trait
7.2.2. Acquired Trait
Chapter 8. Market Segmentation 4: By Test Type Technology Estimates & Trend Analysis
8.1. By Test Type Technology & Market Share, 2020 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Test Type Technology:
8.2.1. PCR
8.2.2. NGS
8.2.2.1. Whole Genome Sequencing
8.2.2.2. Whole Exome Sequencing
8.2.3. Others (Targeted Sequencing, Karyotyping, and FISH)
Chapter 9. Market Segmentation 5: By Age Group Estimates & Trend Analysis
9.1. By Age Group & Market Share, 2020 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Age Group:
9.2.1. Children Age Group
9.2.2. Adult Age Group
Chapter 10. Market Segmentation 6: By End User Estimates & Trend Analysis
10.1. By End User & Market Share, 2020 & 2031
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By End User:
10.2.1. Hospital Laboratories
10.2.2. Diagnostics Laboratories
10.2.3. Genetic Testing Laboratories
10.2.4. Research Laboratories
10.2.5. Other End User
Chapter 11. Respiratory Disease Genetic Testing Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America
11.1.1. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Offering, 2019-2031
11.1.2. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Specialty Type, 2019-2031
11.1.3. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Trait Type, 2019-2031
11.1.4. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Test Type Technology, 2019-2031
11.1.5. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By Age Group, 2019-2031
11.1.6. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts By End User, 2019-2031
11.1.7. North America Respiratory Disease Genetic Testing Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
11.2. Europe
11.2.1. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, 2019-2031
11.2.2. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, 2019-2031
11.2.3. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, 2019-2031
11.2.4. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, 2019-2031
11.2.5. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, 2019-2031
11.2.6. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User, 2019-2031
11.2.7. Europe Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031
11.3. Asia Pacific
11.3.1. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, 2019-2031
11.3.2. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, 2019-2031
11.3.3. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, 2019-2031
11.3.4. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, 2019-2031
11.3.5. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, 2019-2031
11.3.6. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User, 2019-2031
11.3.7. Asia Pacific Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031
11.4. Latin America
11.4.1. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, (US$ Million) 2019-2031
11.4.2. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, (US$ Million) 2019-2031
11.4.3. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, (US$ Million) 2019-2031
11.4.4. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, (US$ Million) 2019-2031
11.4.5. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
11.4.6. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User (US$ Million) 2019-2031
11.4.7. Latin America Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031
11.5. Middle East & Africa
11.5.1. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Offering, (US$ Million) 2019-2031
11.5.2. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Specialty Type, (US$ Million) 2019-2031
11.5.3. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Trait Type, (US$ Million) 2019-2031
11.5.4. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Test Type Technology, (US$ Million) 2019-2031
11.5.5. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By Age Group, (US$ Million) 2019-2031
11.5.6. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) By End User, (US$ Million) 2019-2031
11.5.7. Middle East & Africa Respiratory Disease Genetic Testing Market revenue (US$ Million) by country, 2019-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. 23andMe, Inc.
12.2.2. Centogene A.G.
12.2.3. GeneDx, Inc.
12.2.4. Invitae Corporation
12.2.5. Color Genomics
12.2.6. Myriad Genetics
12.2.7. Medicover Genetics
12.2.8. Blueprint Genetics
12.2.9. Prevention Genetics
12.2.10. Quest Diagnostics
12.2.11. Genesis Genetics
12.2.12. ARUP Laboratories
12.2.13. EGL Genetic Diagnostics
12.2.14. Laboratory Corporation of America Holdings (LabCorp)
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們